Butler John P. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$905,149.20
Insider Sells Quantity
11
Insider Sells Sum
$1.06M

Insider Activity of Butler John P.

According to the SEC Form 4 filings, Butler John P., being in a position of

  1. CEO and President at Akebia Therapeutics, Inc.,
    оver the last 12 months, has bought 69270 shares for $86,588, and sold 341305 shares for $474,414,
    over all time since 2014-03-25, has bought 204970 shares for $991,737, and sold 926381 share for $1.54M.

Biography of Butler John P.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $86,588150
Sells
 $474,414150

Comparison of Insiders on Amount of Buys and Sells

2026-03-04PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
69,270
0.0261%
$1.25$86,588-16.8%
2026-02-02SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
341,305
0.1295%
$1.39$474,414-17.03%
2025-03-03SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
46,409
0.0217%
$1.83$84,928+35%
2025-02-03SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
144,250
0.062%
$2.10$302,925+14.62%
2024-02-29SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
46,570
0.0249%
$1.58$73,581-7.28%
2024-02-27SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
37,733
0.0186%
$1.52$57,354-10.37%
2024-02-01SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
46,489
0.0254%
$1.68$78,102-15.5%
2023-03-01SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
91,868
0.0482%
$0.88$80,614+23.5%
2023-02-27SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
38,632
0.0211%
$0.81$31,416+38.48%
2022-03-01SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
53,973
0.0303%
$2.17$117,159-80.93%
2022-02-28SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
25,053
0.0139%
$2.15$53,984-81.02%
2021-04-01SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
4,109
0.0026%
$3.40$13,971-15.92%
2021-03-01SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
49,990
0.0328%
$3.40$169,771-14.84%
2019-11-20PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
100,000
0.087%
$3.44$344,000+130.84%
2014-12-29PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
2,000
0.0102%
$11.57$23,134-15.05%
2014-12-22PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
2,000
0.0097%
$11.92$23,832-21.16%
2014-12-15PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
2,000
0.0107%
$11.34$22,673-8.88%
2014-11-12PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
2,000
0.0084%
$10.30$20,610-19.78%
2014-03-25PurchaseAkebia Therapeutics, Inc.
AKBA
President and CEO
27,700
1.0572%
$17.00$470,900+3.17%
Total: 19
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.